We are live on ! Find out more
RCYC

Richard C. Young & Co Portfolio holdings

AUM $1.36B
1-Year Est. Return 66.41%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+66.41%
3 Year Est. Return
+137.43%
5 Year Est. Return
+151.84%
10 Year Est. Return
+342.18%
AUM
$524M
AUM Growth
+$55.4M
Cap. Flow
+$13.9M
Cap. Flow %
2.66%
Top 10 Hldgs %
33.63%
Holding
76
New
7
Increased
46
Reduced
15
Closed
7

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$8.63M
2
MRK icon
Merck
MRK
+$8.58M
3
MDT icon
Medtronic
MDT
+$8.48M
4
SNY icon
Sanofi
SNY
+$8.3M
5
NVO
Novo Nordisk
NVO
+$8.25M

Sector Composition

Rank Sector Weight
1 Healthcare 17.71%
2 Industrials 12.75%
3 Consumer Staples 12.33%
4 Financials 12.11%
5 Technology 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$144B
$8.23M 1.57%
+204,227
New +$8.18M
CBRL icon
27
Cracker Barrel
CBRL
$1.2B
$8.14M 1.55%
50,369
+2,455
+5% +$404K
AMT icon
28
American Tower
AMT
$79.9B
$7.64M 1.46%
38,783
+2,112
+6% +$370K
UL icon
29
Unilever
UL
$144B
$7.63M 1.46%
117,485
-1,605
-1% -$97.8K
XOM icon
30
ExxonMobil
XOM
$634B
$7.61M 1.45%
94,212
+25,972
+38% +$1.98M
BA icon
31
Boeing
BA
$175B
$7.61M 1.45%
19,955
-480
-2% -$185K
CVS icon
32
CVS Health
CVS
$140B
$7.36M 1.4%
136,431
+52,721
+63% +$3.25M
WFC.PRL icon
33
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
$6.9M 1.32%
5,337
-135
-2% -$174K
FTS icon
34
Fortis
FTS
$29.7B
$6.79M 1.3%
183,681
+8,772
+5% +$311K
APD icon
35
Air Products & Chemicals
APD
$65.2B
$6.75M 1.29%
35,315
+12,059
+52% +$2.08M
TXN icon
36
Texas Instruments
TXN
$253B
$6.68M 1.28%
63,010
+2,989
+5% +$310K
WBA
37
DELISTED
Walgreens Boots Alliance
WBA
$6.4M 1.22%
101,126
+3,179
+3% +$217K
DIS icon
38
Walt Disney
DIS
$172B
$6.32M 1.21%
56,898
+31,151
+121% +$3.48M
SLV icon
39
iShares Silver Trust
SLV
$27.6B
$6.23M 1.19%
439,077
+9,348
+2% +$136K
ITW icon
40
Illinois Tool Works
ITW
$84.9B
$6.14M 1.17%
42,762
+3,290
+8% +$455K
IBM icon
41
IBM
IBM
$214B
$6.04M 1.15%
44,774
+32,173
+255% +$4.1M
ADI icon
42
Analog Devices
ADI
$178B
$5.91M 1.13%
56,188
+398
+0.7% +$39.9K
PM icon
43
Philip Morris
PM
$312B
$5.9M 1.13%
66,797
-667
-1% -$53.7K
MLPI
44
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
$5.74M 1.1%
252,649
+4,703
+2% +$104K
MSFT icon
45
Microsoft
MSFT
$2.92T
$5.66M 1.08%
47,957
+28,388
+145% +$3.1M
WMT icon
46
Walmart Inc
WMT
$900B
$5.51M 1.05%
169,353
+8,211
+5% +$266K
AVA icon
47
Avista
AVA
$3.46B
$5.23M 1%
128,771
+10,459
+9% +$430K
WEC icon
48
WEC Energy
WEC
$37B
$4.87M 0.93%
61,628
+5,863
+11% +$435K
PSX icon
49
Phillips 66
PSX
$82.5B
$4.81M 0.92%
+50,521
New +$4.8M
TGT icon
50
Target
TGT
$65.5B
$4.66M 0.89%
58,096
-872
-1% -$63.7K

Similar funds

Richard C. Young & Co's Q1 2019 Portfolio in Review

As of Q1 2019, Richard C. Young & Co held 76 positions worth $524M, up 12% from $468M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Richard C. Young & Co's Q1 2019 filing shows 7 new, 46 increased, 15 reduced and 7 closed positions. Its largest new stake was Novartis: 107,520 shares worth $9.26M. The largest sale was Fidelity MSCI Health Care Index ETF, an estimated $34.1M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 6.8% a quarter earlier, followed by Industrials and Consumer Staples.

  • Richard C. Young & Co's largest Q1 2019 buy was Novartis: 107,520 shares worth $9.26M.
  • Richard C. Young & Co added most to JP Morgan Alerian MLP Index ETN 5/24/24 in Q1 2019, an estimated $5.24M increase.
  • Richard C. Young & Co's biggest Q1 2019 reduction was Vanguard Health Care ETF, cutting an estimated $26.8M.
  • Richard C. Young & Co fully exited Fidelity MSCI Health Care Index ETF in Q1 2019, selling an estimated $34.1M.
  • Richard C. Young & Co's ten largest holdings make up 34% of its $524M portfolio in Q1 2019.
  • Richard C. Young & Co opened 7 new positions and closed 7 in Q1 2019.
  • Richard C. Young & Co's portfolio value rose 12% quarter-over-quarter to $524M.

Based on Richard C. Young & Co's 13F filing for Q1 2019, filed 9 May 2019.